This hypothesis is supported by results from mouse experimental models, where the loss of E-cadherin improved cancer cell invasion, but reduced cell proliferation and survival, the number of CTCs in systemic circulation, and dissemination of cancer cells in distant organs. Here, CDH1 is linked to cancer.